1Austin MA. Epidemiology of hypertriglgceridemia and cardiovascular disease [J]. Am J Cardiol, 1999,83: 166.
2Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR[J]. Nucl Acids Res, 2001, 29: 2 002-007.
3Austin MA. Epidemiology of hypertriglgceridemia and cardiovas cular disease [ J]. Am J Cardiol, 1999 , 83 (9): 166.
4Mital S, Zhang X, Zhao G, et al. Simvastin upregulates coronary vascular endothelial nitric oxide production in conscious dogs [ J ]. Am J Physiol Heart Circ Physiol, 2000, 279( 6): H2649.
5Haffner SM, Miettinen H, Stern MP. The homeostasis model in the Sam Antonio Heart Study [J ] . Diabetes Care, 1997,20: 1087-092.
6Haffner SM, Kennedy E, Gonzalez C, et al. A prospective analysis of the HOMA model. The Mexico City Diabetes Study[J]. Diabetes Care, 1996, 19(10): 1 138-141.
7Wolff AA, Rotmen schHH, StanleyWC, et al. Metabolic approaches to the treat ment of ischemic heart disease: the clinicians perspective [J]. Heart Fail Rev, 2002, 7 (2): 187-203.
8Kushner JA. Beta-cell growth: an unusual paradigm 0 f organogenesis that is cyclin D2/Cdk4 dependent [J]. Cell Cycle, 2006, 5 (3) : 234-237.
9Weyer C, Hanson RL, Tataranni PA, et al. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenicrole of relative hyperinsulinemia [ J] . Diabetes, 2000,49(12): 2094-101.
10Bonnefont Rousselot D, Bastard JP, Jaudon MC, et al. Consequences of the diabetic status on the oxidant/antioxidant balance[J]. Diabetes Metab, 2000, 26: 163-176.
